# Pharmacokinetics and Safety Study of LBAL in Healthy Subjects

> **NCT02206867** · PHASE1 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 116 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **BIOLOGICAL:** LBAL
- **BIOLOGICAL:** Humira

## Key facts

- **NCT ID:** NCT02206867
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2015-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02206867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02206867, "Pharmacokinetics and Safety Study of LBAL in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02206867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*